{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:47:42Z","timestamp":1790063262409,"version":"4.0.1"},"reference-count":26,"publisher":"Archives of Endocrinology and Metabolism","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,20]]},"DOI":"10.20945\/2359-4292-2023-0204","type":"journal-article","created":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T16:16:30Z","timestamp":1716394590000},"source":"Crossref","is-referenced-by-count":3,"title":["Podocytopathies associated with familial partial lipodystrophy due to LMNA variants: report of two cases"],"prefix":"10.20945","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1543-6446","authenticated-orcid":false,"given":"Maria Julia","family":"Morguetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1089-6763","authenticated-orcid":false,"given":"Precil Diego Miranda de Menezes","family":"Neves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9837-784X","authenticated-orcid":false,"given":"Ilana","family":"Korkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3716-6058","authenticated-orcid":false,"given":"Wallace Stwart Carvalho","family":"Padilha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3590-0282","authenticated-orcid":false,"given":"Lect\u00edcia Barbosa","family":"Jorge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8053-2968","authenticated-orcid":false,"given":"Andreia","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3371-6019","authenticated-orcid":false,"given":"Elieser Hitoshi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0409-816X","authenticated-orcid":false,"given":"Denise Maria Avancini Costa","family":"Malheiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3208-4435","authenticated-orcid":false,"given":"Irene de Lourdes","family":"Noronha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8653-8773","authenticated-orcid":false,"given":"Sergio Atala","family":"Dib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4053-5419","authenticated-orcid":false,"given":"Luiz Fernando","family":"Onuchic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9048-068X","authenticated-orcid":false,"given":"Regina S.","family":"Mois\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"8510","reference":[{"issue":"12","key":"key20240522121626_B1","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1056\/NEJMra025261","article-title":"Acquired and inherited lipodystrophies","volume":"350","author":"Garg","year":"2004","unstructured":"Garg A. Acquired and inherited lipodystrophies. N Engl J Med. 2004;350(12):1220-34. doi: 10.1056\/NEJMra025261.","journal-title":"N Engl J Med"},{"issue":"7","key":"key20240522121626_B2","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1210\/jc.2003-032140","article-title":"Proteinuric nephropathy in acquired and congenital generalized lipodystrophy: baseline characteristics and course during recombinant leptin therapy","volume":"89","author":"Javor","year":"2004","unstructured":"Javor ED, Moran SA, Young JR, Cochran EK, DePaol, AM, Oral EA, et al. Proteinuric nephropathy in acquired and congenital generalized lipodystrophy: baseline characteristics and course during recombinant leptin therapy. J Clin Endocrinol Metab. 2004;89(7):3199-207. doi: 10.1210\/jc.2003-032140.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"key20240522121626_B3","doi-asserted-by":"crossref","first-page":"534","DOI":"10.2169\/internalmedicine1962.28.534","article-title":"Total lipodystrophy with heart failure and renal failure: report of a case","volume":"28","author":"Ishii","year":"1989","unstructured":"Ishii J, Abe M, Kubo M, Sumimoto T, Hamada M, Hiwada K, et al. Total lipodystrophy with heart failure and renal failure: report of a case. Jpn J Med. 1989;28(4):534-7. doi: 10.2169\/internalmedicine1962.28.534.","journal-title":"Jpn J Med"},{"issue":"9","key":"key20240522121626_B4","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.metabol.2015.06.004","article-title":"Acquired partial lipodystrophy is associated with increased risk for developing metabolic abnormalities","volume":"64","author":"Akinci","year":"2015","unstructured":"Akinci B, Koseoglu FD, Onay H, Yavuz S, Altay C, Simsir IY, et al. Acquired partial lipodystrophy is associated with increased risk for developing metabolic abnormalities. Metabolism. 2015;64(9):1086-95.doi: 10.1016\/j.metabol.2015.06.004.","journal-title":"Metabolism"},{"issue":"11","key":"key20240522121626_B5","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1210\/jc.2018-02730","article-title":"Comorbidities and Survival in Patients With Lipodystrophy: An International Chart Review Study","volume":"104","author":"Akinci","year":"2019","unstructured":"Akinci B, Oral EA, Neidert A, Rus D, Cheng WY, Thompson-Leduc P, et al. Comorbidities and Survival in Patients With Lipodystrophy: An International Chart Review Study. J Clin Endocrinol Metab. 2019;104(11):5120-35. doi: 10.1210\/jc.2018-02730.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"key20240522121626_B6","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/01.md.0000111061.69212.59","article-title":"Clinical features and metabolic and autoimmune derangements in acquired partial lipodystrophy: report of 35 cases and review of the literature","volume":"83","author":"Misra","year":"2004","unstructured":"Misra A, Peethambaram A, Garg A. Clinical features and metabolic and autoimmune derangements in acquired partial lipodystrophy: report of 35 cases and review of the literature. Medicine (Baltimore). 2004;83(1):18-34. doi: 10.1097\/01.md.0000111061.69212.59.","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"key20240522121626_B7","doi-asserted-by":"crossref","first-page":"c35","DOI":"10.1159\/000076396","article-title":"Mesangiocapillary glomerulonephritis type 2 associated with familial partial lipodystrophy (Dunnigan-Kobberling syndrome)","volume":"96","author":"Owen","year":"2004","unstructured":"Owen KR, Donohoe M, Ellard S, Clarke TJ, Nicholls AJ, Hattersley AT, et al. Mesangiocapillary glomerulonephritis type 2 associated with familial partial lipodystrophy (Dunnigan-Kobberling syndrome). Nephron Clin Pract. 2004;96(2):c35-8. doi: 10.1159\/000076396.","journal-title":"Nephron Clin Pract"},{"issue":"12","key":"key20240522121626_B8","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1002\/ajmg.a.32331","article-title":"Extreme phenotypic diversity and nonpenetrance in families with the LMNA gene mutation R644C","volume":"146A","author":"Rankin","year":"2008","unstructured":"Rankin J, Auer-Grumbach M, Bagg W, Colclough K, Nguyen TD, Fenton-May J, et al. Extreme phenotypic diversity and nonpenetrance in families with the LMNA gene mutation R644C. Am J Med Genet A. 2008;146A(12):1530-42. doi: 10.1002\/ajmg.a.32331.","journal-title":"Am J Med Genet A"},{"issue":"1","key":"key20240522121626_B9","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s12020-008-9127-1","article-title":"A case of Dunnigan-type familial partial lipodystrophy (FPLD) due to lamin A\/C (LMNA) mutations complicated by end-stage renal disease","volume":"35","author":"Imachi","year":"2009","unstructured":"Imachi H, Murao K, Ohtsuka S, Fujiwara M, Muraoka T, Hosokawa H, et al. A case of Dunnigan-type familial partial lipodystrophy (FPLD) due to lamin A\/C (LMNA) mutations complicated by end-stage renal disease. Endocrine. 2009;35(1):18-21. doi: 10.1007\/s12020-008-9127-1.","journal-title":"Endocrine"},{"issue":"1-2","key":"key20240522121626_B10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000354716","article-title":"Cosegregation of focal segmental glomerulosclerosis in a family with familial partial lipodystrophy due to a mutation in LMNA","volume":"124","author":"Thong","year":"2013","unstructured":"Thong KM, Xu Y, Cook J, Takou A, Wagner B, Kawar B, et al. Cosegregation of focal segmental glomerulosclerosis in a family with familial partial lipodystrophy due to a mutation in LMNA. Nephron Clin Pract. 2013;124(1-2):31-7. doi: 10.1159\/000354716.","journal-title":"Nephron Clin Pract"},{"key":"key20240522121626_B11","first-page":"17","article-title":"Familial partial lipodystrophy and proteinuric renal disease due to a missense c.1045C > T LMNA mutation","volume":"2017","author":"Fountas","year":"2017","unstructured":"Fountas A, Giotaki Z, Dounousi E, Liapis G, Bargiota A, Tsatsoulis A, et al. Familial partial lipodystrophy and proteinuric renal disease due to a missense c.1045C > T LMNA mutation. Endocrinol Diabetes Metab Case Rep. 2017;2017:17-0049. doi: 10.1530\/EDM-17-0049.","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"1","key":"key20240522121626_B12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/cen.13732","article-title":"Renal complications of lipodystrophy: A closer look at the natural history of kidney disease","volume":"89","author":"Akinci","year":"2018","unstructured":"Akinci B, Unlu SM, Celik A, Simsir IY, Sen S, Nur B, et al. Renal complications of lipodystrophy: A closer look at the natural history of kidney disease. Clin Endocrinol (Oxf). 2018;89(1):65-75. doi: 10.1111\/cen.13732.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"key20240522121626_B13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/72807","article-title":"LMNA, encoding lamin A\/C, is mutated in partial lipodystrophy","volume":"24","author":"Shackleton","year":"2000","unstructured":"Shackleton S, Lloyd DJ, Jackson SN, Evans R, Niermeijer MF, Singh BM, et al. LMNA, encoding lamin A\/C, is mutated in partial lipodystrophy. Nat Genet. 2000;24(2):153-6. doi: 10.1038\/72807.","journal-title":"Nat Genet"},{"issue":"5","key":"key20240522121626_B14","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/cen.13311","article-title":"Spectrum of disease associated with partial lipodystrophy: lessons from a trial cohort","volume":"86","author":"Ajluni","year":"2017","unstructured":"Ajluni N, Meral R, Neidert AH, Brady GF, Buras E, McKenna B, et al. Spectrum of disease associated with partial lipodystrophy: lessons from a trial cohort. Clin Endocrinol (Oxf). 2017;86(5):698-707. doi: 10.1111\/cen.13311.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"key20240522121626_B15","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1530\/EJE-12-0268","article-title":"Phenotypic diversity in patients with lipodystrophy associated with LMNA mutations","volume":"167","author":"Mory","year":"2012","unstructured":"Mory PB, Crispim F, Freire MB, Salles JE, Val\u00e9rio CM, Godoy-Matos AF, et al. Phenotypic diversity in patients with lipodystrophy associated with LMNA mutations. Eur J Endocrinol. 2012;167(3):423-31. doi: 10.1530\/EJE-12-0268.","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"key20240522121626_B16","doi-asserted-by":"crossref","first-page":"bvaa108","DOI":"10.1210\/jendso\/bvaa108","article-title":"Atypical Progeroid Syndrome and Partial Lipodystrophy Due to LMNA Gene p.R349W Mutation","volume":"4","author":"Magno","year":"2020","unstructured":"Magno S, Ceccarini G, Pelosini C, Ferrari F, Prodam F, Gilio D, et al. Atypical Progeroid Syndrome and Partial Lipodystrophy Due to LMNA Gene p.R349W Mutation. J Endocr Soc. 2020;4(10):bvaa108. doi: 10.1210\/jendso\/bvaa108.","journal-title":"J Endocr Soc"},{"key":"key20240522121626_B17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.metabol.2017.04.010","article-title":"Clinical presentations, metabolic abnormalities and end-organ complications in patients with familial partial lipodystrophy","volume":"72","author":"Akinci","year":"2017","unstructured":"Akinci B, Onay H, Demir T, Savas-Erdeve \u015e, Gen R, Simsir IY, et al. Clinical presentations, metabolic abnormalities and end-organ complications in patients with familial partial lipodystrophy. Metabolism. 2017;72:109-19. doi: 10.1016\/j.metabol.2017.04.010.","journal-title":"Metabolism"},{"issue":"6","key":"key20240522121626_B18","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1053\/j.ajkd.2019.12.019","article-title":"Approach to Diagnosis and Management of Primary Glomerular Diseases Due to Podocytopathies in Adults: Core Curriculum 2020","volume":"75","author":"Ahn","year":"2020","unstructured":"Ahn W, Bomback AS. Approach to Diagnosis and Management of Primary Glomerular Diseases Due to Podocytopathies in Adults: Core Curriculum 2020. Am J Kidney Dis. 2020;75(6):955-64. doi: 10.1053\/j.ajkd.2019.12.019.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"key20240522121626_B19","doi-asserted-by":"crossref","first-page":"502","DOI":"10.2215\/CJN.05960616","article-title":"Focal Segmental Glomerulosclerosis","volume":"12","author":"Rosenberg","year":"2017","unstructured":"Rosenberg AZ, Kopp JB. Focal Segmental Glomerulosclerosis. Clin J Am Soc Nephrol. 2017;12(3):502-17. doi: 10.2215\/CJN.05960616.","journal-title":"Clin J Am Soc Nephrol"},{"key":"key20240522121626_B20","doi-asserted-by":"crossref","first-page":"1032653","DOI":"10.3389\/fped.2022.1032653","article-title":"Case report: Focal segmental glomerulosclerosis in a pediatric atypical progeroid syndrome","volume":"10","author":"Jang","year":"2022","unstructured":"Jang S, Ahn YH, Ko JM, Ko JS, Lim S, Kang HG. Case report: Focal segmental glomerulosclerosis in a pediatric atypical progeroid syndrome. Front Pediatr. 2022;10:1032653. doi: 10.3389\/fped.2022.1032653.","journal-title":"Front Pediatr"},{"issue":"3","key":"key20240522121626_B21","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s12020-009-9265-0","article-title":"LMNA gene mutation search in Polish patients: new features of the heterozygous Arg482Gln mutation phenotype","volume":"36","author":"Klupa","year":"2009","unstructured":"Klupa T, Szopa M, Skupien J, Wojtyczek K, Cyganek K, Kowalska I, et al. LMNA gene mutation search in Polish patients: new features of the heterozygous Arg482Gln mutation phenotype. Endocrine. 2009;36(3):518-23. doi: 10.1007\/s12020-009-9265-0.","journal-title":"Endocrine"},{"issue":"2","key":"key20240522121626_B22","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1464-5491.2009.02909.x","article-title":"Post-mortem findings in Dunnigan-type familial partial lipodystrophy","volume":"27","author":"L\u00fcdtke","year":"2010","unstructured":"L\u00fcdtke A, Roos GM, van Hettinga M, Horst BA, Worman HJ, Schmidt HH. Post-mortem findings in Dunnigan-type familial partial lipodystrophy. Diabet Med. 2010;27(2):245-6. doi: 10.1111\/j.1464-5491.2009.02909.x.","journal-title":"Diabet Med"},{"issue":"1-2","key":"key20240522121626_B23","first-page":"116","article-title":"Minimal change disease with partial lipodystrophy","volume":"9","author":"Jacob","year":"1988-1989","unstructured":"Jacob CK, Date A, Shastry JC. Minimal change disease with partial lipodystrophy. Child Nephrol Urol. 1988-1989;9(1-2):116-7.","journal-title":"Child Nephrol Urol"},{"issue":"6","key":"key20240522121626_B24","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1093\/jmcb\/mju041","article-title":"SREBP-1 is a novel mediator of TGF\u03b21 signaling in mesangial cells","volume":"6","author":"Chen","year":"2014","unstructured":"Chen G, Wang T, Uttarwar L, vanKrieken R, Li R, Chen X, et al. SREBP-1 is a novel mediator of TGF\u03b21 signaling in mesangial cells. J Mol Cell Biol. 2014;6(6):516-30. doi: 10.1093\/jmcb\/mju041.","journal-title":"J Mol Cell Biol"},{"issue":"7","key":"key20240522121626_B25","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1093\/hmg\/ddu728","article-title":"The p.R482W substitution in A-type lamins deregulates SREBP1 activity in Dunnigan-type familial partial lipodystrophy","volume":"24","author":"Vadrot","year":"2015","unstructured":"Vadrot N, Duband-Goulet I, Cabet E, Attanda W, Barateau A, Vicart P, et al. The p.R482W substitution in A-type lamins deregulates SREBP1 activity in Dunnigan-type familial partial lipodystrophy. Hum Mol Genet. 2015;24(7):2096-109. doi: 10.1093\/hmg\/ddu728.","journal-title":"Hum Mol Genet"},{"issue":"11","key":"key20240522121626_B26","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1172\/JCI119815","article-title":"Hepatic fibrosis, glomerulosclerosis, and a lipodystrophy-like syndrome in PEPCK-TGF-beta1 transgenic mice","volume":"100","author":"Clouthier","year":"1997","unstructured":"Clouthier DE, Comerford SA, Hammer RE. Hepatic fibrosis, glomerulosclerosis, and a lipodystrophy-like syndrome in PEPCK-TGF-beta1 transgenic mice. The J Clin Invest. 1997;100(11):2697-713. doi: 10.1172\/JCI119815.","journal-title":"The J Clin Invest"}],"container-title":["Archives of Endocrinology and Metabolism"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T16:16:45Z","timestamp":1716394605000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aem-sbem.com\/article\/podocytopathies-associated-with-familial-partial-lipodystrophy-due-to-lmna-variants-report-of-two-cases\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":26,"alternative-id":["10.20945\/2359-4292-2023-0204"],"URL":"https:\/\/doi.org\/10.20945\/2359-4292-2023-0204","relation":{},"ISSN":["2359-3997","2359-4292"],"issn-type":[{"value":"2359-3997","type":"print"},{"value":"2359-4292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"e230204"}}